id,drug1,object,drug2,precipitant,certainty,contraindication,dateAdded,ddiPkEffect,ddiPkMechanism,effectConcept,homepage,label,numericVal,objectUri,pathway,precaution,precipUri,severity,uri,whoAnnotated,source,ddiType,evidence,evidenceSource,evidenceStatement,researchStatementLabel,researchStatement,managementOptions
37,http://bio2rdf.org/drugbank:DB00641,SIMVASTATIN,http://bio2rdf.org/drugbank:DB00343,DILTIAZEM,None,None,"05/29/2007 10:27:50",http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/increases_auc,None,None,http://dbmi-icode-01.dbmi.pitt.edu/dikb-evidence/diltiazem_increases_auc_simvastatin.html,"diltiazem increases the AUC of simvastatin ",4.817,None,None,None,None,None,http://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIObservations47,boycer,DIKB,DDIObservation,http://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/Evidence/830,http://www.ncbi.nlm.nih.gov/pubmed/10741630,"|Route of administration: oral|polymorphic enzyme: NO|study duration: 14 days diltiazem pretreatment|population: 5 male, 5 women|ages:19-35|(mean AUC_i)/(mean AUC) = 55.4/11.5|description: |A fixed-order study was conducted in 10 healthy volunteers with a 2-week washout period between the phases. In one arm of the study, a single 20-mg dose of simvastatin was administered orally; the second arm entailed administration of a single 20-mg dose of simvastatin orally after 2 weeks of treatment with 120 mg diltiazem twice a day. RESULTS: Diltiazem significantly increased the mean peak serum concentration of simvastatin by 3.6-fold (P < .05) and simvastatin acid by 3.7-fold (P < .05). Diltiazem also significantly increased the area under the serum concentration-time curve of simvastatin 5-fold (P < .05) and the elimination half-life 2.3-fold (P < .05).",diltiazem_increases_auc_simvastatin,http://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/Assertions/689,None
210,http://bio2rdf.org/drugbank:DB00641,simvastatin,http://bio2rdf.org/drugbank:DB00343,diltiazem,None,None,None,None,None,None,None,"diltiazem is predicted to reduce the clearance of simvastatin by inhibition of CYP3A4",None,None,http://purl.obolibrary.org/obo/PR_000006130,None,None,None,http://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/395,None,DIKB,DDIPrediction,None,None,None,None,None,None
16268,http://bio2rdf.org/drugbank:DB00641,Simvastatin,http://bio2rdf.org/drugbank:DB00343,Diltiazem,None,None,None,None,None,None,None,"Diltiazem may increase the serum concentration of simvastatin. Simvastatin may increase the serum concentration of diltiazem. Monitor for changes in the therapeutic and adverse effects of both agents if concomitant therapy is initiated, discontinued or if doses are changed.|",None,None,None,None,None,None,None,None,Drugbank,None,None,None,None,None,None,None
26569,http://bio2rdf.org/drugbank:DB00641,SIMVASTATIN,http://bio2rdf.org/drugbank:DB00343,Diltiazem,None,None,None,None,None,None,None,"DILTIAZEM/SIMVASTATIN [VA Drug Interaction]",None,None,None,None,None,Significant,http://purl.bioontology.org/ontology/NDFRT/N0000033997,None,NDF-RT,None,None,None,None,None,None,None
81643,http://bio2rdf.org/drugbank:DB00641,Simvastatin,http://bio2rdf.org/drugbank:DB00343,DILTIAZEM,None,None,None,None,None,None,None,None,None,None,None,None,None,None,None,None,NLM-Corpus,true,None,None,Caution_Interaction,None,None,None
82068,http://bio2rdf.org/drugbank:DB00641,Simvastatin,http://bio2rdf.org/drugbank:DB00343,Diltiazem,None,None,None,None,None,None,None,None,None,None,None,None,None,None,None,None,ONC-HighPriority,None,None,None,None,None,None,None
